Month: December 2021

HRSA Adds Three Days to 1Q 340B Registration Period

In Federal, RegulatoryDecember 23, 2021244 Views

The first 340B covered entity registration period of the year will be Jan. 1-18, 2022, for an effective start date of April 1, 2022.

Eligible hospitals, health centers, clinics, and their child sites and contract pharmacies registered during

…

Referral Prescription Capture Drives Significant 340B Savings Enhancing 340B’s Mission

In Sponsored ContentDecember 23, 2021857 Views

OVERVIEW

Establishing a referral prescription capture program enables covered entities to broaden the reach of their 340B Drug Discount Program. Referral prescription capture can occur when patients of the covered entity utilize external specialists who are outside of the health system’s physician network.

Monitoring these opportunities not only increases the prescription volume that qualifies as 340B eligible, but

…

More Than 850 Hospitals Ask Feds to Appeal Judge’s 340B Contract Pharmacy Ruling

In Federal, Judicial, Pharma Industry, Regulatory, Trade AssociationDecember 21, 2021501 Views

Tom Mirga

850+ hospitals in the 340B program sent the HHS secretary a letter yesterday asking the government to appeal a judge’s 340B contract pharmacy ruling.

Just over 850 hospitals in the 340B program asked the federal government yesterday to appeal a judge’s Nov. 5 ruling that halted enforcement actions against two drug companies that deny 340B pricing when hospitals and others use contract

…

Provider Groups Pan Lilly’s 340B Contract Pharmacy Policy Change

In Pharma Industry, Trade AssociationDecember 21, 2021479 Views

Tom Mirga

Groups representing health care providers have panned Lilly's recent 340B contract pharmacy policy change.

Groups representing 340B health centers, Ryan White clinics, and hospitals panned drug manufacturer Lilly’s recent decision to amend its prohibition on 340B pricing when providers use contract pharmacies to dispense drugs to patients.

Lilly told drug wholesaler

…

Is There a New 340B Stakeholder Group for Pharma Companies?

In Pharma Industry, Research/ReportsDecember 21, 2021449 Views

Tom Mirga

A new infographic by a drug industry consultant indicates it was created for the 340B Industry Roundtable—an apparently new 340B drug industry stakeholder group.

A new two-pager about the 340B program by drug industry consultant Berkeley Research Group (BRG) indicates it was created for the 340B Industry Roundtable—an apparently new 340B drug industry stakeholder group.

The infographic came to light Sunday.

…

Democratic Defection on Build Back Better Act Sets Back Drive to Lower Drug Prices

In Federal, LegislativeDecember 21, 2021243 Views

Tom Mirga

U.S. Sen. Joe Manchin’s (D-W.Va.) rejection of his fellow Democrats’ Build Back Better (BBB) policy agenda left its drug pricing section dead in the water.

West Virginia U.S. Sen. Joe Manchin’s rejection Sunday of his fellow Democrats’ Build Back Better (BBB) policy agenda left its drug pricing section dead in the water.

Manchin said of the BBA bill on Dec. 19, “I cannot

…

Cloudmed Acquires 340B Technology Company par8o

In Other IndustryDecember 21, 2021270 Views

Ron Shinkman

Boston-based par8o, which provides 340B services including a platform to help 340B covered entities manage their patient referral claims, has been acquired by Cloudmed.

Cloudmed is a revenue intelligence company based in Atlanta. The company partners with over

…

News Alert: Carole Johnson Will Take Over as HRSA Administrator in January

In Federal, RegulatoryDecember 17, 2021997 Views

Tom Mirga

White House COVID-19 testing czar Carole Johnson will become the next head of the U.S. Health Resources and Services Administration in January.

White House COVID-19 testing czar and long-time Democratic health policy expert Carole Johnson will become the next head of the U.S. Health Resources and Services Administration (HRSA) in January.

HRSA Acting Administrator Diana Espinosa announced Johnson’s selection this

…

Breaking News: Lilly Will Honor Unlimited 340B Contract Pharmacy Arrangements in Exchange for Entities’ Claims Data

In Pharma IndustryDecember 16, 20211578 Views

Tom Mirga

Drug manufacturer Lilly will let 340B covered entities buy medicines for shipment to an unlimited number of contract pharmacies if entities agree to provide claims-level data associated with such orders.

340B hospitals

…

U.S. Retail Drug Spending Hit $348.4 Billion in 2020 but Overall Prices Fell 0.1%

In Federal, Research/ReportsDecember 16, 2021386 Views

Tom Mirga

U.S. retail prescription drug spending hit $348.4 billion in 2020 but overall prices declined slightly, a new federal report shows.

U.S. retail prescription drug spending hit $348.4 billion in 2020, constituting 8% of total health care expenditures, a new federal report shows.

The U.S. Centers for Medicare & Medicaid Services (CMS) yesterday published its annual national health care

…

OVERVIEW

Site Footer